FOSUN HEALTH Logo

Leukemia Causes

catalogue

Leukemia Causes

Leukemia Causes

Most leukemia has no identifiable cause, and it is worth saying so at the outset, because the question patients ask first is usually whether something they did caused it. The risk factors that are established are few, and they are mostly medical events rather than choices: a previous cancer treated with chemotherapy or radiotherapy, exposure to benzene in an occupational setting, a preceding disorder of the bone marrow, or an inherited predisposition. Understanding how those operate is what separates the factors that matter from the ones that circulate without evidence.

Previous cancer treatment

The strongest established risk factor for leukemia is treatment given for something else. This is uncomfortable to state, and important to state accurately, because it is a risk that arises from a decision that was correct at the time:

  • Alkylating agents — a group of chemotherapy drugs used in many cancers, associated with leukemia that typically appears several years later, often after a phase of abnormal blood counts.
  • Topoisomerase II inhibitors — a different group, associated with leukemia that appears sooner and often carries a specific chromosome rearrangement.
  • Radiotherapy — an increased risk related to the dose delivered to the marrow, which is one reason radiotherapy fields are designed to spare as much marrow as possible.
  • The balance of benefit — for most patients treated for a previous cancer, the benefit of that treatment substantially exceeds the leukemia risk, which is why the treatment was recommended.

Two points follow. Doctors treating a patient who has had previous chemotherapy or radiotherapy are alert to the possibility, which is why an unexplained blood count abnormality in that setting is investigated rather than watched — and why mentioning a previous cancer at any haematology consultation matters. And if you are facing a decision about chemotherapy or radiotherapy now, the question worth asking is not whether it carries any risk but how that risk compares with the benefit of the treatment being proposed; that comparison is what the recommendation rests on.

Benzene and other exposures

A smaller number of leukemias are linked to what the body has been exposed to at work or in the environment. The evidence is strongest for one agent and weaker for the rest:

  • Benzene — the best established occupational cause of leukemia, which is why strict exposure limits exist for it. It is present in petroleum products and in some industrial processes, and exposure is relevant in industries that handle it.
  • Other organic solvents — associated in some studies with leukemia and lymphoma, though less consistently than benzene.
  • Ionising radiation at high dose — including therapeutic radiation and, historically, occupational exposure, with the risk related to dose.
  • Smoking — linked specifically to acute myeloid leukemia, and covered separately below.
  • Pesticides and hair dyes — studied repeatedly, with inconsistent findings; these are frequently cited concerns that the data do not strongly support.

Because benzene risk operates at a population level and accumulates over years, an occupational history is a piece of information only the patient can provide. It is worth mentioning at a first consultation if you have worked in an industry that handles petroleum products, solvents or industrial chemicals — particularly in settings where protective equipment was limited. What should not follow is retrospective alarm: the increase in risk for one person from ordinary incidental exposure is small, and it is not a reason to attribute an illness to a decision made years ago.

Preceding marrow disorders and inherited predisposition

A proportion of leukemias arise either from a marrow that was already abnormal or from an inherited susceptibility. Both are uncommon, and both matter because they change how patients and families are advised:

  • A preceding myelodysplastic syndrome or myeloproliferative neoplasm — a group of disorders in which the marrow produces abnormal cells, and which can evolve into acute leukemia over months or years, which is one reason such disorders are monitored.
  • Down syndrome — associated with a substantially higher risk of leukemia, both myeloid and lymphoid, and treated on protocols designed for it.
  • Inherited predisposition syndromes — including germline changes in genes such as RUNX1, CEBPA or GATA2, and conditions such as Fanconi anaemia and Li-Fraumeni syndrome, each with its own implications for treatment and for relatives.
  • Bone marrow failure syndromes — including severe aplastic anaemia and its inherited forms, which carry an increased risk of clonal evolution into leukemia.

Smoking

Smoking is the most common modifiable risk factor for leukemia, and its link is specifically with acute myeloid leukemia rather than with all types:

  • Benzene as a component of tobacco smoke — the mechanism is at least partly the same as occupational benzene exposure, since tobacco smoke contains it.
  • A modest but consistent increase in risk — the effect is real and reproducible across studies, though far smaller for leukemia than smoking's effect on lung cancer.
  • Risk that falls after stopping — it declines over the years after quitting, which is one more reason that stopping is worthwhile at any age, though it does not return to the level of somebody who never smoked.

What does not cause leukemia

Leukemia attracts explanations that have little evidence behind them, and because the diagnosis is frightening and the cause usually unknown, those explanations find an audience. The following are worth naming:

  • Stress. Psychological stress does not cause leukemia, although it affects how patients cope with treatment.
  • Diet and food additives. No diet has been shown to cause or prevent leukemia.
  • Mobile phones, power lines and household electromagnetic fields. Studied extensively; the evidence does not establish a causal link at ordinary levels of exposure.
  • Vaccination and infection. Vaccines do not cause leukemia; a few infections are associated with specific rare leukemias, which is a different matter from the common infections of childhood.
  • Personality or attitude. There is no evidence that how someone approaches life affects the risk of developing the disease.

The reason to list these is that a belief in an avoidable cause often carries guilt with it — the sense, in a disease of unknown cause, that something should have been done differently. For most patients nothing should have been: no identifiable factor was present, and no preventive measure would have applied. Where a recognised factor does exist, it is usually a medical treatment or an occupational exposure rather than anything chosen.

Who is at higher risk — and who is not

Putting the factors together, certain groups carry a higher risk than the general population:

  • People treated with chemotherapy or radiotherapy for a previous cancer, particularly with alkylating agents or topoisomerase II inhibitors, years after that treatment.
  • People with sustained occupational exposure to benzene, and to a lesser degree to other organic solvents.
  • People with a myelodysplastic syndrome or a myeloproliferative neoplasm, or with a marrow failure syndrome.
  • People with Down syndrome, and those with an inherited predisposition syndrome or a family history of a related condition.
  • Smokers, for acute myeloid leukemia specifically, and people in older age groups generally.

Two honest qualifications belong here. Being in one of these groups does not mean a person will develop leukemia — most people in every one of these categories never do, and the increases are relative rather than absolute. And not being in any of them removes only a little of the risk, because most patients with leukemia have no identifiable risk factor at all. That is why an abnormal blood count is investigated on its own merits rather than according to a risk profile, and why this page should be read as an explanation of mechanism rather than as a list of things to have been worried about. For anyone in the groups above, the useful behaviour is prompt assessment of a new or unexplained blood result, and the reasoning is set out on the prevention page.

Frequently Asked Questions

Did I do something that caused this?

In the great majority of cases, no — there is no identifiable cause, which is true of most people with leukemia and is worth stating plainly. The recognised risk factors are medical events a person did not choose, such as previous cancer treatment, an occupational exposure, or an inherited condition. Even where one is present, it raises the statistical risk across a group rather than explaining an individual case, and many people with the same exposure never develop leukemia. The question patients most often carry is about a missed symptom or a period of stress, and neither of those causes the disease.

Is leukemia hereditary?

Mostly not. The majority of leukemias occur without any family history and without an inherited predisposition. There are exceptions: Down syndrome raises the risk substantially, and rarer syndromes involving genes such as RUNX1, CEBPA and GATA2 are inherited in families and have implications for relatives and for donor selection. Outside those situations, there is no recommended genetic testing or screening for relatives of an ordinary patient. If two or more close relatives have had leukemia or a related marrow disorder, that is worth raising with a specialist.

Can an infection or a vaccine cause leukemia?

Vaccines do not cause leukemia. A small number of infections are associated with specific rare leukemias — the human T-lymphotropic virus with a particular T-cell leukemia, and Epstein-Barr virus with some rare aggressive forms — but these are unusual diseases and the associations concern populations, not transmissible risk. Ordinary childhood infections, which are very common, have no established causal role. If you have been told otherwise, it is worth checking the source.

Can I prevent leukemia?

There is no way to prevent it reliably, and no screening test that would find it early. The measures with evidence behind them are specific rather than general: not smoking, using protective equipment in occupations that handle benzene or organic solvents, and taking part in monitoring if you have a preceding marrow disorder such as a myelodysplastic syndrome, where regular blood counts can detect evolution early. None of these is a guarantee, and none explains most cases. What is within a patient's control is the response to an abnormal blood result or a new set of symptoms — having it assessed rather than waiting for the next routine appointment.

Patient Stories

Stories from our leukemia programme, pulled automatically from the patient story library by disease tag.

View all patient stories →

Ask whether any risk factor applies in your case

Send the diagnosis, the subtype, the treatment history and any relevant past medical or occupational history. Our haematology team will return a written assessment within 48 hours of the file being complete, including whether any of the recognised associations is relevant to your case.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*